SCHEMBL14701790

SCHEMBL14701790

Cc1cc(C(C)(C)C)cc(C)c1-c1ccc2c(c1)-c1cccc3c(N)c(C(=O)O)cc-2c13

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRB P28702 5/20 0.40
MYC P01106 1/20 0.36
HKDC1 Q2TB90 1/20 0.35
MPL P40238 1/20 0.35
TYMS P04818 1/20 0.34
POLB P06746 1/20 0.34
IL1B P01584 1/20 0.34
RXRA P19793 4/20 0.33
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 1/20 0.33
AKR1C2 P52895 1/20 0.33
AKR1C1 Q04828 1/20 0.33
MCL1 Q07820 2/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
THRB P10828 1/20 0.33
PKM P14618 1/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14701788 0.91 MYC (0.43) MYCHKDC1MPLTYMSPOLB
SCHEMBL14701827 0.85 HKDC1 (0.40) RXRBHKDC1TYMSPOLBRXRA
SCHEMBL14701776 0.79 HKDC1 (0.44) HKDC1TYMSPOLBKDM4EALDH1A1
SCHEMBL14700581 0.79 HKDC1 (0.36) HKDC1KDM4EMAPTPABPC1SMN1; SMN2
SCHEMBL10046313 0.77 HKDC1 (0.56) MYCHKDC1TYMSPOLBKDM4E
SCHEMBL12179670 0.77 HKDC1 (0.42) HKDC1TYMSPOLBKDM4EALDH1A1
SCHEMBL12179526 0.75 HKDC1 (0.46) HKDC1POLBKDM4EALDH1A1MAPT
SCHEMBL12179723 0.71 HKDC1 (0.45) HKDC1POLBKDM4EALDH1A1MAPT
SCHEMBL14701820 0.71 HKDC1 (0.43) MYCHKDC1TYMSPOLBKDM4E
SCHEMBL12179577 0.70 HNF4A (0.46) MYCHKDC1TYMSPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9005778-B2 Organic compound and organic light-emitting device including the same CANON KABUSHIKI KAISHA (JP) 2015-04-14 US disclosed
US-20130038515-A1 NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130038515-A1 NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME TYR, CYP3A4, DDT RXRB 1263/4885MYC 1090/4885HKDC1 2302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.